About this trial
ORIGINS-VRCE-2 is an observational study aimed to assess how blood vessel forming stem cells from individuals without diabetes or a history of cardiovascular disease differ between individuals of South Asian and European ethnicities. The overarching objective of the study is to investigate whether differential vessel reparative stem cell populations and characteristics may underlie the elevated cardiovascular risk observed among South Asian individuals compared to individuals of European origins.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults 18 years of age or older of South Asian origin or European origin as defined by the following: i. South Asian defined as any individual who identifies as Anglo-Indian, Bangladeshi, Bengali, Bhutanese, Goan, Gujarati, Indian, Jatt, Kashmiri, Maharashtrian, Malayali, Nepali, Pakistani, Punjabi, Sindhi, Sinhalese, Sri Lankan, Tamil, Telugu, or other South Asian origins. ii. European Origin defined as any individual who identifies as from western Europe, northern Europe, southern Europe, eastern Europe or other European origins.
Willing and able to provide written informed consent and comply with study requirements
Must fulfill the following
Disqualifiers
No previous diagnosis of type 2 diabetes
Prior myocardial infarction
Coronary revascularization
Coronary artery disease, peripheral artery disease, cerebrovascular disease
Trial population
Participants will be identified from primary care and cardiology outpatient clinics in the Greater Toronto Area using paper-based and electronic medical records.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The differences in the frequency / absolute number of circulating ALDHhi primitive progenitor cells co-expressing CD133 between individuals of South Asian origins and European origins
Secondary outcomes
The differences in the frequency / absolute number of circulating ALDHhiSSCmid precursor cells with monocytes/macrophage phenotype between individuals of South Asian origins and European origin
Other outcomes
Difference in the amount of intracellular reactive oxygen species (ROS) production in ALDHhi progenitor cell subsets in individuals of South Asian origins and European origins
Difference in the levels of inflammatory and oxidative stress biomarkers in individuals of South Asian origins and European origins
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Canadian Medical and Surgical Knowledge Translation Research Group
Lead sponsor
Unity Health Toronto
Collaborator
Western University, Canada
Collaborator